Axiom Investors’s Loxo Oncology, Inc LOXO Stock Holding History

Axiom Investors’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-10,992	Closed	-$1.54M	–	144
2018 Q4	$1.54M	Sell	10,992 -5,028	-31%	-$763K	0.05%	115
2018 Q3	$2.74M	Sell	16,020 -6,417	-29%	-$1.08M	0.08%	105
2018 Q2	$3.89M	Buy	22,437 +6,509	+41%	+$978K	0.12%	98
2018 Q1	$1.84M	Sell	15,928 -7,189	-31%	-$765K	0.05%	125
2017 Q4	$1.95M	Buy	+23,117	New	+$1.93M	0.05%	123

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Axiom Investors's LOXO Position: Q1 2019 in Review

Axiom Investors sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 10,992 shares — an estimated $1.54M sold.

Axiom Investors first reported a position in LOXO in Q4 2017 and held it in 5 quarters. The position peaked at $3.89M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Axiom Investors reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Axiom Investors sold 10,992 Loxo Oncology, Inc shares in Q1 2019, an estimated $1.54M.
Axiom Investors first reported a position in Loxo Oncology, Inc in Q4 2017 and held it in 5 quarters.
Axiom Investors's Loxo Oncology, Inc position peaked at $3.89M in Q2 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Axiom Investors's 13F filing for Q1 2019, filed 13 May 2019.